In this study, we found that after developing resistance to oxalipatin, gastric cancer cells exhibit elevated levels of JMJD3, which mediates the upregulation of ALOX5 and allows the cells to survive and proliferate in the presence of OXA, accompanied by higher levels of reactive oxygen species (ROS). The gene discussed is ALOX5; the disease is gastric cancer.